LFCR · Lifecore Biomedical, Inc. \De\
$4.39
+0.05 (+1.15%)
At close · Jul 28
Market Cap
$162.79M
Shares
37.51M
Lifecore Biomedical, Inc. \De\ Earnings Call Transcripts
Every quarterly earnings call for Lifecore Biomedical, Inc. \De\ (LFCR) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
·
$26.60M
−$1.28M
'21 Q4
21-07-28
▼1.5%
$22.33M
−$9.39M
'22 Q1
21-09-29
▲7.6%
$25.60M
−$38.47M
'22 Q2
22-01-05
▲26.7%
$35.23M
−$13.59M
'22 Q3
22-04-05
▲5.7%
$28.11M
−$55.27M
'22 Q4
22-08-10
▲6.2%
$23.72M
−$10.97M
'23 Q1
22-10-06
▼24.7%
$26.54M
−$36.51M
'23 Q3
23-03-16
▲10.8%
$31.14M
−$39.28M
'23 Q4
23-08-31
▲21.6%
$37.88M
−$7.08M
'24 Q4
24-08-26
▲0.7%
$24.70M
−$16.23M
'25 Q1
24-10-04
▲8%
$32.56M
−$6.57M
'25 Q2
25-01-02
▼1.5%
$35.15M
−$14.77M
'25 Q3
25-04-03
▼3.8%
$36.44M
−$1.15M
'25 Q4
25-08-07
▲25.9%
$31.11M
−$9.99M
'26 Q1
25-11-06
▼3.8%
$36.44M
−$1.15M
'25 Q4
26-03-16
LATEST
▲25.9%
$31.11M
−$9.99M
'26 Q1
26-05-06
Earnings call
FY26 · Q1
2026-05-06
Lifecore Biomedical, Inc. \De\ Q3 FY2026 Earnings Call
Revenue
$31.11M
▲ 25.9% YoY Diluted EPS
$-0.29
Gross margin
25.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-16
Q4 2025 Lifecore Biomedical Earnings Conference Call
Revenue
$36.44M*
▼ 3.8% YoY Gross margin
38.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY26 · Q1
2025-11-06
Lifecore Biomedical, Inc. \De\ Q1 FY2026 Earnings Call
Revenue
$31.11M
▲ 25.9% YoY Diluted EPS
$-0.29
Gross margin
25.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-08-07
Lifecore Biomedical, Inc. \De\ Q4 FY2025 Earnings Call
Revenue
$36.44M*
▼ 3.8% YoY Gross margin
38.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-04-03
Lifecore Biomedical, Inc. \De\ Q3 FY2025 Earnings Call
Positive tone
Revenue and earnings results
Customer pipeline and business development
Liquidity and cash flow
Revenue
$35.15M
▼ 1.5% YoY Diluted EPS
$-0.42
▼ 200% YoY Gross margin
28.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-01-02
Lifecore Biomedical, Inc. \De\ Q2 FY2025 Earnings Call
Revenue
$32.56M
▲ 8% YoY Diluted EPS
$-0.25
▼ 164.1% YoY Gross margin
34.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2024-10-04
Lifecore Biomedical, Inc. \De\ Q1 FY2025 Earnings Call
Confident tone
Second-half weighted financial outlook
New business wins and pipeline
Capital raise and liquidity
Revenue
$24.70M
▲ 0.7% YoY Diluted EPS
$-0.53
Gross margin
21.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-08-26
Lifecore Biomedical, Inc. \De\ Q4 FY2024 Earnings Call
Positive tone
FY24 revenue and profitability recovery
Restructuring, recentralization and cost reduction
CDMO services growth
Revenue
$37.88M*
▲ 21.6% YoY Gross margin
45.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q4
2023-08-31
Lifecore Biomedical, Inc. \De\ Q4 FY2023 Earnings Call
Revenue
$31.14M*
▲ 10.8% YoY Gross margin
25.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-03-16
Lifecore Biomedical, Inc. \De\ Q3 FY2023 Earnings Call
Revenue
$26.54M
▼ 24.7% YoY Diluted EPS
$-1.20
Gross margin
32.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2022-10-06
Lifecore Biomedical, Inc. \De\ Q1 FY2023 Earnings Call
Revenue
$23.72M
▲ 6.2% YoY Diluted EPS
$-0.37
Gross margin
25.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-08-10
Lifecore Biomedical, Inc. \De\ Q4 FY2022 Earnings Call
Revenue
$28.11M*
▲ 5.7% YoY Gross margin
37.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-04-05
Lifecore Biomedical, Inc. \De\ Q3 FY2022 Earnings Call
Revenue
$35.23M
▲ 26.7% YoY Diluted EPS
$-0.46
Gross margin
33.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-01-05
Lifecore Biomedical, Inc. \De\ Q2 FY2022 Earnings Call
Revenue
$25.60M
▲ 7.6% YoY Diluted EPS
$-1.31
Gross margin
44.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2021-09-29
Lifecore Biomedical, Inc. \De\ Q1 FY2022 Earnings Call
Revenue
$22.33M
▼ 1.5% YoY Diluted EPS
$-0.32
Gross margin
24.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-07-28
Lifecore Biomedical, Inc. \De\ Q4 FY2021 Earnings Call
Revenue
$26.60M*
Gross margin
44.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-04-07
Lifecore Biomedical, Inc. \De\ Q3 FY2021 Earnings Call
Revenue
$27.81M
▼ 81.8% YoY Diluted EPS
$-0.24
Gross margin
39.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-01-06
Lifecore Biomedical, Inc. \De\ Q2 FY2021 Earnings Call
Revenue
$23.79M
▼ 83.3% YoY Diluted EPS
$-0.40
Gross margin
45.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2020-10-06
Lifecore Biomedical, Inc. \De\ Q1 FY2021 Earnings Call
Revenue
$22.68M
▼ 83.7% YoY Diluted EPS
$-0.42
Gross margin
23.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-08-11
Lifecore Biomedical, Inc. \De\ Q4 FY2020 Earnings Call
Revenue
$*
▼ 279.5% YoY Gross margin
4.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-03-31
Lifecore Biomedical, Inc. \De\ Q3 FY2020 Earnings Call
Revenue
$152.93M
▼ 1.7% YoY Diluted EPS
$-0.39
▼ 1075% YoY Gross margin
13.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-01-02
Lifecore Biomedical, Inc. \De\ Q2 FY2020 Earnings Call
Revenue
$142.59M
▲ 14.5% YoY Diluted EPS
$-0.23
Gross margin
10.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–22 of 22 earnings calls
Key facts
CIK
1005286
CUSIP
514766104
13F (30d)
16 filings
16 filers
Visit website
Investor relations